Mead Johnson confirms talks on proposed takeover by Reckitt Benckiser for USD 90 per share
While it is the longstanding policy of Mead Johnson Nutrition (NYSE:MJN) not to comment on market speculation or rumors, in response to media reports and a subsequent statement released by Reckitt Benckiser plc (LON:RB), the company confirms that it is in discussions with RB with respect to its proposal to acquire the outstanding shares of MJN for USD 90 per share in cash.
Mead Johnson notes that no agreement has been completed, and there are no assurances that any transaction will result from these discussions. The company does not intend to make any additional comments regarding this matter unless and until a formal agreement has been reached or discussions have been terminated.
Mead Johnson remains committed to doing what is best for its shareholders, employees and, as always, the children, families and health care professionals around the world who trust and depend on its products and expertise.